Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice

International Journal of Molecular Sciences(2020)10.3390/ijms21207581Source: DataRank Database

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice is a research paper published in International Journal of Molecular Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.02)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Melissa Vitela,K. Clarke ORCID,Wouter Koek ORCID,Lynette C. Daws ORCID,Melodi A. Bowman ORCID

Live enrichment

PubMed:33066466 PMC:PMC7589995 OpenAlex:https://openalex.org/W3092969389

National Institutes of Health

Grant: R01MH093320

National Institutes of Health

Grant: R01MH106978

NINDS NIH HHS

Grant: T32 NS082145

National Institutes of Health

Grant: 5R01MH106978-03

Age-related differences in serotonin clearance: novel targets for antidepressants

National Institutes of Health

Grant: 5R01MH093320-08

Role of the serotonin transporter and organic cation transporter 3 in serotonergic modulation of emotion-regulating circuitry

FWCI

3.02

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/21/20/7581/pdf?version=1602670991

publisherhttps://www.mdpi.com/1422-0067/21/20/7581/pdf?version=1602670991

publisherhttps://www.mdpi.com/1422-0067/21/20/7581/pdf

journalhttps://doi.org/10.3390/ijms21207581

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33066466

Fields of Study

Treatment of Major DepressionTryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior03 medical and health sciences0302 clinical medicineAnimalsAntidepressive AgentsCA3 Region, HippocampalEquilibrative Nucleoside Transport ProteinsKetamineMaleMiceMice, Inbred C57BLNucleus AccumbensSerotoninSerotonin Plasma Membrane Transport Proteins

MeSH Terms

AnimalsAntidepressive AgentsKetamineMaleMice, Inbred C57BLNucleus AccumbensSerotoninEquilibrative Nucleoside Transport ProteinsSerotonin Plasma Membrane Transport ProteinsMiceCA3 Region, Hippocampal

Keywords

AntidepressantSerotonin transporterSerotoninMonoamine neurotransmitterSerotonin Plasma Membrane Transport ProteinsPharmacologyNeurochemicalReuptakeSerotonin Uptake InhibitorsKetamineReuptake inhibitorChemistryInternal medicineEndocrinologyBiologyMedicineFluoxetineNeuroscienceReceptorHippocampusIsofluraneTail Suspension TestForced Swim TestChronoamperometryAntidepressant-like ActivitySerotonin ClearancePlasma Membrane Monoamine TransporterMaleCA3 Region, HippocampalArticleAntidepressive AgentsNucleus AccumbensMice, Inbred C57BLMiceEquilibrative Nucleoside Transport ProteinsAnimals

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being